GPCRmd uncovers the dynamics of the 3D-GPCRome.


Journal

Nature methods
ISSN: 1548-7105
Titre abrégé: Nat Methods
Pays: United States
ID NLM: 101215604

Informations de publication

Date de publication:
08 2020
Historique:
received: 08 01 2020
accepted: 29 05 2020
pubmed: 15 7 2020
medline: 5 11 2020
entrez: 15 7 2020
Statut: ppublish

Résumé

G-protein-coupled receptors (GPCRs) are involved in numerous physiological processes and are the most frequent targets of approved drugs. The explosion in the number of new three-dimensional (3D) molecular structures of GPCRs (3D-GPCRome) over the last decade has greatly advanced the mechanistic understanding and drug design opportunities for this protein family. Molecular dynamics (MD) simulations have become a widely established technique for exploring the conformational landscape of proteins at an atomic level. However, the analysis and visualization of MD simulations require efficient storage resources and specialized software. Here we present GPCRmd (http://gpcrmd.org/), an online platform that incorporates web-based visualization capabilities as well as a comprehensive and user-friendly analysis toolbox that allows scientists from different disciplines to visualize, analyze and share GPCR MD data. GPCRmd originates from a community-driven effort to create an open, interactive and standardized database of GPCR MD simulations.

Identifiants

pubmed: 32661425
doi: 10.1038/s41592-020-0884-y
pii: 10.1038/s41592-020-0884-y
doi:

Substances chimiques

Receptors, G-Protein-Coupled 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

777-787

Subventions

Organisme : NIH HHS
ID : S10 OD018522
Pays : United States
Organisme : NIH HHS
ID : S10 OD026880
Pays : United States

Commentaires et corrections

Type : ErratumIn

Références

Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schiöth, H. B. & Gloriam, D. E. Trends in GPCR drug discovery: mew agents, targets and indications. Nat. Rev. Drug Discov. 16, 829–842 (2017).
pubmed: 6882681 pmcid: 6882681
Munk, C. et al. GPCRdb in 2018: adding GPCR structure models and ligands. Nucleic Acids Res. 46, 440–446 (2017).
Munk, C. et al. An online resource for GPCR structure determination and analysis. Nat. Methods 16, 151–162 (2019).
doi: 10.1038/s41592-018-0302-x
Latorraca, N. R., Venkatakrishnan, A. J. & Dror, R. O. GPCR dynamics: structures in motion. Chem. Rev. 117, 139–155 (2017).
doi: 10.1021/acs.chemrev.6b00177
Hildebrand, P. W., Rose, A. S. & Tiemann, J. K. S. Bringing molecular dynamics simulation data into view. Trends Biochem. Sci. 44, 902–913 (2019).
doi: 10.1016/j.tibs.2019.06.004
Rose, A. S. & Hildebrand, P. W. NGL Viewer: a web application for molecular visualization. Nucleic Acids Res. 43, W576–W579 (2015).
doi: 10.1093/nar/gkv402
Tiemann, J. K. S., Guixà-González, R., Hildebrand, P. W. P. W. & Rose, A. S. MDsrv: viewing and sharing molecular dynamics simulations on the web. Nat. Methods 14, 1123–1124 (2017).
doi: 10.1038/nmeth.4497
Carrillo-Tripp, M. et al. HTMoL: full-stack solution for remote access, visualization, and analysis of molecular dynamics trajectory data. J. Comput. Aided Mol. Des. 32, 869–876 (2018).
doi: 10.1007/s10822-018-0141-y
Wilkinson, M. D. et al. The FAIR guiding principles for scientific data management and stewardship. Sci. Data 3, 160018 (2016).
doi: 10.1038/sdata.2016.18
Hauser, A. S. et al. Pharmacogenomics of GPCR drug targets. Cell 172, 41–54 (2018).
doi: 10.1016/j.cell.2017.11.033
Munk, C., Harpsøe, K., Hauser, A. S., Isberg, V. & Gloriam, D. E. Integrating structural and mutagenesis data to elucidate GPCR ligand binding. Curr. Opin. Pharmacol. 30, 51–58 (2016).
doi: 10.1016/j.coph.2016.07.003
Isberg, V. et al. Generic GPCR residue numbers - aligning topology maps while minding the gaps. Trends Pharmacol. Sci. 36, 22–31 (2015).
doi: 10.1016/j.tips.2014.11.001
Venkatakrishnan, A. J. et al. Uncovering patterns of atomic interactions in static and dynamic structures of proteins. Preprint at bioRxiv https://doi.org/10.1101/840694 (2019).
Liu, W. et al. Structural basis for allosteric regulation of GPCRs by sodium ions. Science 337, 232–236 (2012).
doi: 10.1126/science.1219218
Yuan, S., Filipek, S., Palczewski, K. & Vogel, H. Activation of G-protein-coupled receptors correlates with the formation of a continuous internal water pathway. Nat. Commun. 5, 4733 (2014).
doi: 10.1038/ncomms5733
Hildebrand, P. W. et al. A ligand channel through the G protein coupled receptor opsin. PloS ONE 4, e4382 (2009).
doi: 10.1371/journal.pone.0004382
Guixà-González, R. et al. Membrane cholesterol access into a G-protein-coupled receptor. Nat. Commun. 8, 14505 (2017).
doi: 10.1038/ncomms14505
Venkatakrishnan, A. J. et al. Diverse GPCRs exhibit conserved water networks for stabilization and activation. Proc. Natl Acad. Sci. USA 116, 3288–3293 (2019).
doi: 10.1073/pnas.1809251116
Alexander, S. P. et al. The concise guide to pharmacology 2017/18: G protein-coupled receptors. Br. J. Pharmacol. 174, S17–S129 (2017).
doi: 10.1111/bph.13878
Roth, C. B., Hanson, M. A. & Stevens, R. C. Stabilization of the human β2-adrenergic receptor TM4-TM3-TM5 helix interface by mutagenesis of Glu1223.41, a critical residue in GPCR structure. J. Mol. Biol. 376, 1305–1319 (2008).
doi: 10.1016/j.jmb.2007.12.028
Selent, J., Sanz, F., Pastor, M. & De Fabritiis, G. Induced effects of sodium ions on dopaminergic G-protein coupled receptors. PLoS Comput. Biol. 6, e1000884 (2010).
doi: 10.1371/journal.pcbi.1000884
Zarzycka, B., Zaidi, S. A., Roth, B. L. & Katritch, V. Harnessing ion-binding sites for GPCR pharmacology. Pharmacol. Rev. 71, 571–595 (2019).
doi: 10.1124/pr.119.017863
Selvam, B., Shamsi, Z. & Shukla, D. Universality of the sodium ion binding mechanism in class A G-protein-coupled receptors. Angew. Chem. 130, 3102–3107 (2018).
doi: 10.1002/ange.201708889
Yuan, S., Vogel, H. & Filipek, S. The role of water and sodium ions in the activation of the μ-Opioid receptor. Angew. Chem. 52, 1–5 (2013).
doi: 10.1002/anie.201209858
Gutiérrez-De-Terán, H. et al. The role of a sodium ion binding site in the allosteric modulation of the A2A adenosine G protein-coupled receptor. Structure 21, 2175–2185 (2013).
doi: 10.1016/j.str.2013.09.020
Bostock, M. J., Solt, A. S. & Nietlispach, D. The role of NMR spectroscopy in mapping the conformational landscape of GPCRs. Curr. Opin. Struct. Biol. 57, 145–156 (2019).
doi: 10.1016/j.sbi.2019.03.030
Wingler, L. M. et al. Angiotensin analogs with divergent bias stabilize distinct receptor conformations. Cell 176, 468–478 (2019).
doi: 10.1016/j.cell.2018.12.005
Gregorio, G. G. et al. Single-molecule analysis of ligand efficacy in β2AR–G-protein activation. Nature 547, 68–73 (2017).
doi: 10.1038/nature22354
Sommer, M. E. et al. The European Research Network on Signal Transduction (ERNEST): toward a multidimensional holistic understanding of G protein-coupled receptor signaling. ACS Pharmacol. Transl. Sci. 3, 361–370 (2020).
doi: 10.1021/acsptsci.0c00024
Ballesteros, J. A. et al. Activation of the β2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J. Biol. Chem. 276, 29171–29177 (2001).
doi: 10.1074/jbc.M103747200
Mayol, E. et al. HomolWat: a web server tool to incorporate ‘homologous’ water molecules into GPCR structures. Nucleic Acids Res. (in the press); https://doi.org/10.1093/nar/gkaa440
Buch, I., Harvey, M. J., Giorgino, T., Anderson, D. P. & De Fabritiis, G. High-throughput all-atom molecular dynamics simulations using distributed computing. J. Chem. Inf. Model. 50, 397–403 (2010).
doi: 10.1021/ci900455r
Heller, S. R., McNaught, A., Pletnev, I., Stein, S. & Tchekhovskoi, D. InChI, the IUPAC International Chemical Identifier. J. Cheminformatics 7, 23 (2015).
doi: 10.1186/s13321-015-0068-4
Southan, C. et al. The IUPHAR/BPS Guide to pharmacology in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucleic Acids Res. 44, D1054–D1068 (2016).
doi: 10.1093/nar/gkv1037
Gilson, M. K. et al. BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucleic Acids Res. 44, D1045–D1053 (2016).
doi: 10.1093/nar/gkv1072
Berman, H. M. et al. The Protein Data Bank. Nucleic Acids Res. 28, 235–242 (2000).
doi: 10.1093/nar/28.1.235
Karczewski, K. J. et al. Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. Preprint at bioRxiv 531210 (2019).
Gowers, R. J. et al. MDAnalysis: a python package for the rapid analysis of molecular dynamics simulations. In Proc. 15th Python Sci. Conference 98–105 (2016).
McGibbon, R. T. et al. MDTraj: a modern open library for the analysis of molecular dynamics trajectories. Biophys. J. 109, 1528–1532 (2015).
doi: 10.1016/j.bpj.2015.08.015
Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph. 14, 33–38 (1996).
doi: 10.1016/0263-7855(96)00018-5
Chovancova, E. et al. CAVER 3.0: a tool for the analysis of transport pathways in dynamic protein structures. PLoS Comput. Biol. 8, 23–30 (2012).
doi: 10.1371/journal.pcbi.1002708
Virtanen, P. et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat. Methods 17, 261–272 (2020).
doi: 10.1038/s41592-019-0686-2

Auteurs

Ismael Rodríguez-Espigares (I)

Research Programme on Biomedical Informatics, Hospital del Mar Medical Research Institute-Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona, Spain.

Mariona Torrens-Fontanals (M)

Research Programme on Biomedical Informatics, Hospital del Mar Medical Research Institute-Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona, Spain.

Johanna K S Tiemann (JKS)

Institute of Medical Physics and Biophysics, Charite University Medicine Berlin, Berlin, Germany.
Institute of Medical Physics and Biophysics, Medical University Leipzig, Leipzig, Sachsen, Germany.

David Aranda-García (D)

Research Programme on Biomedical Informatics, Hospital del Mar Medical Research Institute-Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona, Spain.

Juan Manuel Ramírez-Anguita (JM)

Research Programme on Biomedical Informatics, Hospital del Mar Medical Research Institute-Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona, Spain.

Tomasz Maciej Stepniewski (TM)

Research Programme on Biomedical Informatics, Hospital del Mar Medical Research Institute-Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona, Spain.

Nathalie Worp (N)

Research Programme on Biomedical Informatics, Hospital del Mar Medical Research Institute-Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona, Spain.

Alejandro Varela-Rial (A)

Computational Science Laboratory, Universitat Pompeu Fabra, Barcelona Biomedical Research Park, Barcelona, Spain.
Acellera, Barcelona, Spain.

Adrián Morales-Pastor (A)

Research Programme on Biomedical Informatics, Hospital del Mar Medical Research Institute-Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona, Spain.

Brian Medel-Lacruz (B)

Research Programme on Biomedical Informatics, Hospital del Mar Medical Research Institute-Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona, Spain.

Gáspár Pándy-Szekeres (G)

Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.

Eduardo Mayol (E)

Laboratori de Medicina Computacional, Unitat de Bioestadistica, Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain.

Toni Giorgino (T)

Biophysics Institute, National Research Council of Italy, Milan, Italy.
Department of Biosciences, University of Milan, Milan, Italy.

Jens Carlsson (J)

Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.

Xavier Deupi (X)

Laboratory of Biomolecular Research, Paul Scherrer Institute (PSI), Villigen PSI, Switzerland.
Condensed Matter Theory Group, PSI, Villigen PSI, Switzerland.

Slawomir Filipek (S)

Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw, Warsaw, Poland.

Marta Filizola (M)

Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

José Carlos Gómez-Tamayo (JC)

Laboratori de Medicina Computacional, Unitat de Bioestadistica, Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain.

Angel Gonzalez (A)

Laboratori de Medicina Computacional, Unitat de Bioestadistica, Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain.

Hugo Gutiérrez-de-Terán (H)

Department of Cell and Molecular Biology, Uppsala University, Biomedical Center, Uppsala, Sweden.

Mireia Jiménez-Rosés (M)

Laboratori de Medicina Computacional, Unitat de Bioestadistica, Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain.

Willem Jespers (W)

Department of Cell and Molecular Biology, Uppsala University, Biomedical Center, Uppsala, Sweden.

Jon Kapla (J)

Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.

George Khelashvili (G)

Department of Physiology and Biophysics, Weill Cornell Medical College of Cornell University, New York, NY, USA.
Institute for Computational Biomedicine, Weill Cornell Medical College of Cornell University, New York, NY, USA.

Peter Kolb (P)

Department of Pharmaceutical Chemistry, Philipps-University Marburg, Marburg, Germany.

Dorota Latek (D)

Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw, Warsaw, Poland.

Maria Marti-Solano (M)

Department of Pharmaceutical Chemistry, Philipps-University Marburg, Marburg, Germany.
MRC Laboratory of Molecular Biology, Cambridge, UK.

Pierre Matricon (P)

Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.

Minos-Timotheos Matsoukas (MT)

Laboratori de Medicina Computacional, Unitat de Bioestadistica, Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain.
Department of Pharmacy, University of Patras, Patras, Greece.

Przemyslaw Miszta (P)

Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw, Warsaw, Poland.

Mireia Olivella (M)

Laboratori de Medicina Computacional, Unitat de Bioestadistica, Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain.

Laura Perez-Benito (L)

Laboratori de Medicina Computacional, Unitat de Bioestadistica, Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain.

Davide Provasi (D)

Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Santiago Ríos (S)

Laboratori de Medicina Computacional, Unitat de Bioestadistica, Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain.

Iván R Torrecillas (I)

Laboratori de Medicina Computacional, Unitat de Bioestadistica, Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain.

Jessica Sallander (J)

Department of Cell and Molecular Biology, Uppsala University, Biomedical Center, Uppsala, Sweden.

Agnieszka Sztyler (A)

Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw, Warsaw, Poland.

Silvana Vasile (S)

Department of Cell and Molecular Biology, Uppsala University, Biomedical Center, Uppsala, Sweden.

Harel Weinstein (H)

Department of Physiology and Biophysics, Weill Cornell Medical College of Cornell University, New York, NY, USA.
Institute for Computational Biomedicine, Weill Cornell Medical College of Cornell University, New York, NY, USA.

Ulrich Zachariae (U)

Computational Biology, School of Life Sciences, University of Dundee, Dundee, UK.
Physics, School of Science and Engineering, University of Dundee, Dundee, UK.

Peter W Hildebrand (PW)

Institute of Medical Physics and Biophysics, Charite University Medicine Berlin, Berlin, Germany.
Institute of Medical Physics and Biophysics, Medical University Leipzig, Leipzig, Sachsen, Germany.
Berlin Institute of Health, Berlin, Germany.

Gianni De Fabritiis (G)

Computational Science Laboratory, Universitat Pompeu Fabra, Barcelona Biomedical Research Park, Barcelona, Spain.
Acellera, Barcelona, Spain.

Ferran Sanz (F)

Research Programme on Biomedical Informatics, Hospital del Mar Medical Research Institute-Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona, Spain.

David E Gloriam (DE)

Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.

Arnau Cordomi (A)

Laboratori de Medicina Computacional, Unitat de Bioestadistica, Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain.

Ramon Guixà-González (R)

Laboratory of Biomolecular Research, Paul Scherrer Institute (PSI), Villigen PSI, Switzerland. ramon.guixa@psi.ch.
Condensed Matter Theory Group, PSI, Villigen PSI, Switzerland. ramon.guixa@psi.ch.

Jana Selent (J)

Research Programme on Biomedical Informatics, Hospital del Mar Medical Research Institute-Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona, Spain. jana.selent@upf.edu.

Articles similaires

Selecting optimal software code descriptors-The case of Java.

Yegor Bugayenko, Zamira Kholmatova, Artem Kruglov et al.
1.00
Software Algorithms Programming Languages
Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria

Exploring blood-brain barrier passage using atomic weighted vector and machine learning.

Yoan Martínez-López, Paulina Phoobane, Yanaima Jauriga et al.
1.00
Blood-Brain Barrier Machine Learning Humans Support Vector Machine Software
alpha-Synuclein Humans Animals Mice Lewy Body Disease

Classifications MeSH